Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials. Dienstmann R. Ann Oncol 2023;34:962-963.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dienstmann R. Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials. Ann Oncol 2023;34:962-963.
PMID: 37996169